Stock Research for INN

INN

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

INN Stock Chart & Research Data

The INN chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the INN chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


INN Due diligence Resources & Stock Charts

The INN stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View INN Detailed Price Forecast - CNN Money CNN View INN Detailed Summary - Google Finance
Yahoo View INN Detailed Summary - Yahoo! Finance Zacks View INN Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View INN Trends & Analysis - Trade-Ideas Barrons View INN Major Holders - Barrons
NASDAQ View INN Call Transcripts - NASDAQ Seeking View INN Breaking News & Analysis - Seeking Alpha
Spotlight View INN Annual Report - CompanySpotlight.com OTC Report View INN OTC Short Report - OTCShortReport.com
TradeKing View INN Fundamentals - TradeKing Charts View INN SEC Filings - Bar Chart
WSJ View Historical Prices for INN - The WSJ Morningstar View Performance/Total Return for INN - Morningstar
MarketWatch View the Analyst Estimates for INN - MarketWatch CNBC View the Earnings History for INN - CNBC
StockMarketWatch View the INN Earnings - StockMarketWatch MacroAxis View INN Buy or Sell Recommendations - MacroAxis
Bullish View the INN Bullish Patterns - American Bulls Short Pains View INN Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View INN Stock Mentions - StockTwits PennyStocks View INN Stock Mentions - PennyStockTweets
Twitter View INN Stock Mentions - Twitter Invest Hub View INN Investment Forum News - Investor Hub
Yahoo View INN Stock Mentions - Yahoo! Message Board Seeking Alpha View INN Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for INN - SECform4.com Insider Cow View Insider Transactions for INN - Insider Cow
CNBC View INN Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for INN - OTC Markets
Yahoo View Insider Transactions for INN - Yahoo! Finance NASDAQ View Institutional Holdings for INN - NASDAQ


Stock Charts

FinViz View INN Stock Insight & Charts - FinViz.com StockCharts View INN Investment Charts - StockCharts.com
BarChart View INN Stock Overview & Charts - BarChart Trading View View INN User Generated Charts - Trading View




Latest Financial News for INN


Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
Posted on Monday April 22, 2024

Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), is pleased to announce that is has reached a key milestone: the Company submitted its letter of application for a Pre-IND meeting, the first phase in the FDA approval process in the United States for Innocan's Liposome-Cannabidiol (LPT-CBD) injectable treatment of chronic pain.


Innocan Pharma Reports Full Year 2023 Results with Revenues up Nearly 6X to $13.7M
Posted on Monday April 01, 2024

Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies is pleased to announce its audited financial consolidated results for the year ended December 31, 2023.


SUMMIT HOTEL PROPERTIES ANNOUNCES FIRST QUARTER 2024 EARNINGS RELEASE DATE
Posted on Tuesday March 26, 2024

Summit Hotel Properties, Inc. (NYSE: INN) (the "Company") today announced that it will report financial results for the first quarter of 2024 on Wednesday, May 1, 2024, after the market closes.


Innocan Pharma paves its way to LPT-CBD Chemistry, Manufacturing and Controls (CMC), key milestones for FDA approval.
Posted on Monday March 25, 2024

Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the development of drug delivery technologies using CBD for the pharmaceutical and biotechnology industries, is pleased to announce the signing of an agreement with the Hebrew University, which facilitate Innocan to initiate the Food and Drug Administration (FDA) approval process for its liposome CBD platform (LPT-CBD) in accordance with FDA's Chemistry Manufacturing Control (CDC) Guidelin


Stock Market & Investing Books

Enter a stock symbol to view the stock details.